Julia Joung

Active 2008–2025

29
Papers
28,435
Citations
26
h-index
27
i10-index

Citations

Citations per year for Julia Joung1977: 1 citations1983: 1 citations1994: 1 citations1998: 1 citations2001: 2 citations2006: 1 citations2008: 7 citations2009: 10 citations2010: 12 citations2011: 15 citations2012: 16 citations2013: 13 citations2014: 12 citations2015: 87 citations2016: 283 citations2017: 356 citations2018: 564 citations2019: 1,286 citations2020: 1,773 citations2021: 2,115 citations2022: 2,066 citations2023: 1,600 citations2024: 2,312 citations2025: 1,235 citations2026: 15 citations1978–1982: no citations, so these years are not shown1984–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown1999–2000: no citations, so these years are not shown2002–2005: no citations, so these years are not shown2007: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,096 citing papers, 26.4% of this breakdownUnited States: 3,018 citing papers, 25.8% of this breakdownGermany: 510 citing papers, 4.4% of this breakdownUnited Kingdom: 504 citing papers, 4.3% of this breakdownIndia: 414 citing papers, 3.5% of this breakdownSouth Korea: 335 citing papers, 2.9% of this breakdownCanada: 277 citing papers, 2.4% of this breakdownAustralia: 246 citing papers, 2.1% of this breakdownJapan: 246 citing papers, 2.1% of this breakdownNetherlands: 192 citing papers, 1.6% of this breakdownFrance: 177 citing papers, 1.5% of this breakdownSpain: 168 citing papers, 1.4% of this breakdown
0%26.4%Other 21.6%

Fields

  • Biochemistry, Genetics and Molecular Biology77.2%
  • Medicine12.2%
  • Engineering3.4%
  • Agricultural and Biological Sciences2.2%
  • Immunology and Microbiology2%
  • Neuroscience1.3%
  • Other1.7%

Topics

  • CRISPR and Genetic Engineering22.2%
  • Advanced biosensing and bioanalysis techniques8%
  • RNA and protein synthesis mechanisms5%
  • Biosensors and Analytical Detection4.4%
  • RNA Interference and Gene Delivery2.4%
  • RNA regulation and disease2.4%
  • Other55.6%

Coauthors

All papers

Open in search
  1. Nucleic acid detection with CRISPR-Cas13a/C2c2

    Authors: , , , , , , , , , , , , , , , , , , - Science 2017 cited by 3,942

  2. Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System

    Authors: , , , , , , , , , , , - Cell 2015 cited by 4,975

  3. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

    Authors: , , , , , - Science 2018 cited by 2,704

  4. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector

    Authors: , , , , , , , , , , , , , , - Science 2016 cited by 2,428

  5. RNA targeting with CRISPR–Cas13

    Authors: , , , , , , , , , , , , , - Nature 2017 cited by 2,158

  6. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

    Authors: , , , , , , , , , , , - Nature 2014 cited by 2,980

  7. RNA editing with CRISPR-Cas13

    Authors: , , , , , , - Science 2017 cited by 1,849

  8. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

    Authors: , , , , , , , - Nature Protocols 2017 cited by 1,349

  9. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems

    Authors: , , , , , , , , , , , - Molecular Cell 2015 cited by 1,252

  10. Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 804

  11. CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 349

  12. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jirawat Swangsri, Suebwong Chuthapisith, Yongyut Sirivatanauksorn, Chutikarn Chaimayo, Ruengpung Sutthent, Wannee Kantakamalakul, Julia Joung, Alim Ladha, Xin Jin, Jonathan S. Gootenberg, Omar O. Abudayyeh, Feng Zhang, Navin Horthongkham, Chayasith Uttamapinant - Nature Biomedical Engineering 2020 cited by 662

  13. A transcription factor atlas of directed differentiation

    Authors: , , , , , , , , , , , , , , , , , - Cell 2023 cited by 238

  14. CRISPR technologies for genome, epigenome and transcriptome editing

    Authors: , , , , , - Nature Reviews Molecular Cell Biology 2024 cited by 215

  15. A cytosine deaminase for programmable single-base RNA editing

    Authors: , , , , , , , , , - Science 2019 cited by 470

  16. Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2023 cited by 151

  17. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity

    Authors: , , , , , , , , , , - Nature Communications 2022 cited by 113

  18. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood

    Authors: , , , , , , , , , , , , , , - Nature 2017 cited by 447

  19. Point-of-care testing for COVID-19 using SHERLOCK diagnostics

    Authors: , , , , , , , , , , , , , , - medRxiv 2020 cited by 337

  20. A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Navin Horthongkham, Danaya Pakotiprapha, Chayasith Uttamapinant - The CRISPR Journal 2022 cited by 37

  21. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease

    Authors: , , , , , - Nature Biotechnology 2015 cited by 288

  22. Unexpected failure rates for modular assembly of engineered zinc fingers

    Authors: , , , , , , , , , , , , - Nature Methods 2008 cited by 424

  23. Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma

    Authors: , , , , , , , , , , - Cell Death and Disease 2021 cited by 33

  24. Application of CRISPR genetic screens to investigate neurological diseases

    Authors: , , , , , , , , , , - Molecular Neurodegeneration 2019 cited by 36